CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 35 filers reported holding CONMED CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $938 | -26.2% | 810,000 | 0.0% | 0.01% | -18.2% |
Q2 2023 | $1,271 | +27.1% | 810,000 | 0.0% | 0.01% | +22.2% |
Q1 2023 | $1,000 | +5.8% | 810,000 | 0.0% | 0.01% | +12.5% |
Q4 2022 | $945 | -100.0% | 810,000 | -81.2% | 0.01% | -85.7% |
Q3 2022 | $4,738,000 | -10.0% | 4,310,000 | 0.0% | 0.06% | -1.8% |
Q2 2022 | $5,263,000 | -28.9% | 4,310,000 | 0.0% | 0.06% | -16.2% |
Q1 2022 | $7,405,000 | +57.1% | 4,310,000 | +53.4% | 0.07% | +61.9% |
Q4 2021 | $4,714,000 | +7.8% | 2,810,000 | 0.0% | 0.04% | -12.5% |
Q3 2021 | $4,373,000 | -4.4% | 2,810,000 | 0.0% | 0.05% | +4.3% |
Q2 2021 | $4,576,000 | +3.6% | 2,810,000 | 0.0% | 0.05% | +4.5% |
Q1 2021 | $4,416,000 | -69.4% | 2,810,000 | -72.5% | 0.04% | -73.5% |
Q4 2020 | $14,415,000 | +46.7% | 10,200,000 | +17.2% | 0.17% | +33.9% |
Q3 2020 | $9,824,000 | +6.2% | 8,700,000 | 0.0% | 0.12% | +1.6% |
Q2 2020 | $9,248,000 | +17.2% | 8,700,000 | +3.6% | 0.12% | +2.5% |
Q1 2020 | $7,894,000 | – | 8,400,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 44,065,000 | $71,296,000 | 7.64% |
Mohican Financial Management, LLC | 3,000,000 | $4,878,000 | 1.90% |
SHENKMAN CAPITAL MANAGEMENT INC | 9,398,000 | $15,357,000 | 1.40% |
OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $14,433,000 | 0.74% |
SSI INVESTMENT MANAGEMENT LLC | 6,454,000 | $10,396,000 | 0.67% |
MACKAY SHIELDS LLC | 38,286,000 | $61,845,000 | 0.58% |
PALISADE CAPITAL MANAGEMENT, LP | 5,208,000 | $8,417,000 | 0.19% |
Calamos Advisors LLC | 23,085,000 | $37,345,000 | 0.17% |
Polar Asset Management Partners Inc. | 10,000,000 | $16,168,000 | 0.17% |
Calamos Wealth Management LLC | 1,026,000 | $1,660,000 | 0.13% |